tirzepatide & semaglutide vs Tirzepatide: Which Is Better for Weight Loss? Tirzepatide vs. Semaglutide: What's Better

Phase 2 Clinical Data (NEJM, 2023) The landmark Phase 2 Retatrutide trial (NEJM, June 2023) is the primary clinical evidence base for researcher interest in this compound

This personalized approach means your dose can increase as needed without your monthly cost increasing

This could make semaglutide less effective for weight loss, as the person might eat more, counteracting the benefits of semaglutide

Call us at (586) 287-7330 to schedule a consultation or ask about our programs

Adherence to the trial regimen averaged 89% of the planned time during the study period

The three possibilities Base case: EVOKE shows a modest but convincing difference on CDRSB at two years with slowing of cognitive impairment in the range that we already accept from gold standard treatment